Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Intangibles: 2019-2024

Historic Intangibles for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to $312,000.

  • Silence Therapeutics' Intangibles fell 10.51% to $300,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $300,000, marking a year-over-year decrease of 10.51%. This contributed to the annual value of $312,000 for FY2024, which is 13.81% down from last year.
  • Latest data reveals that Silence Therapeutics reported Intangibles of $312,000 as of FY2024, which was down 13.81% from $362,000 recorded in FY2023.
  • Silence Therapeutics' Intangibles' 5-year high stood at $396,035 during FY2022, with a 5-year trough of $137,404 in FY2020.
  • For the 3-year period, Silence Therapeutics' Intangibles averaged around $356,678, with its median value being $362,000 (2023).
  • In the last 5 years, Silence Therapeutics' Intangibles surged by 121.42% in 2022 and then decreased by 13.81% in 2024.
  • MRY analysis of 5 years shows Silence Therapeutics' Intangibles stood at $137,404 in 2020, then skyrocketed by 30.17% to $178,864 in 2021, then skyrocketed by 121.42% to $396,035 in 2022, then dropped by 8.59% to $362,000 in 2023, then decreased by 13.81% to $312,000 in 2024.
  • Its last three reported values are $312,000 in FY2024, $362,000 for FY2023, and $396,035 during FY2022.